Mitochondrial dysfunction has become one of the most actively studied areas in cellular biology, with research interest spanning oxidative stress, bioenergetics, age-related cellular decline, and the broader question of how mitochondrial integrity supports tissue function. The SS-31 peptide has emerged as a leading mitochondria-targeted peptide in this research space, distinguished by its selective concentration at the inner mitochondrial membrane and its documented interaction with cardiolipin. 

Also referenced in clinical research literature as elamipretide, SS-31 is a Szeto-Schiller peptide designed for mitochondrial membrane targeting. This article explains what SS-31 is, how it is discussed in mitochondrial research, and why its mechanism is commonly evaluated through oxidative-stress, bioenergetic, membrane-stability, and tissue-function models. 

This discussion focuses on peptide identity, proposed mechanisms, non-clinical research contexts, documentation standards, and laboratory-use limitations rather than therapeutic guidance. 

Key Takeaways

• SS-31 is a synthetic tetrapeptide and a member of the Szeto-Schiller peptide family, also known as elamipretide in clinical research.
• SS-31 functions as a mitochondria-targeted peptide that selectively concentrates at the inner mitochondrial membrane.
• Research has documented SS-31’s interaction with cardiolipin in the inner mitochondrial membrane.
• SS-31 appears in pre-clinical literature on oxidative stress, age-related mitochondrial decline, and bioenergetics.
• SS-31 differs from other mitochondria-targeted peptides like MOTS-c by mechanism and research focus.
• SS-31 is intended for laboratory research use only and is supported by third-party U.S. laboratory testing.

What Is SS-31 Peptide, and What Is It Studied For in Mitochondrial Research?

SS-31 is a synthetic tetrapeptide developed by Hazel Szeto and Peter Schiller, designed to selectively concentrate at the inner mitochondrial membrane and interact with cardiolipin in pre-clinical research models. It is referenced as elamipretide in clinical research literature and as SS-31 in preclinical research literature, with both designations pointing to the same molecule. The compound is a leading research tool in the broader category of mitochondrial-targeted peptides, and its research interest spans oxidative stress models, cristae structural studies, and bioenergetic investigations.

The SS-31 mitochondrial peptide carries a distinctive structural feature: an alternating aromatic-cationic amino acid motif that drives its selective concentration at the inner mitochondrial membrane independent of membrane potential. This structural design is the basis for its classification as a Szeto-Schiller peptide and underpins its function as a mitochondria-targeted research compound. Pre-clinical research has examined SS-31 across cellular and animal models, with endpoints focused on mitochondrial structure, function, and resilience under stress conditions.

SS-31 Molecular Identity and Origin

SS-31 has the peptide sequence D-Arg-2′,6′-dimethylTyr-Lys-Phe-NH2, a synthetic tetrapeptide composed of four amino acid residues, including non-standard components such as 2′,6′-dimethyltyrosine. The alternating aromatic-cationic motif is the defining structural feature of the Szeto-Schiller peptide family and is what gives SS-31 its selective affinity for the inner mitochondrial membrane. The peptide originated in research conducted in the Szeto and Schiller laboratories, with the SS designation referring to that origin.

SS-31 Research Profile at a Glance

The table below summarizes SS-31’s identity, mechanism, and research positioning in a single view.

SS-31 Research Profile

Attribute	SS-31 Peptide Profile
Alternate name	Elamipretide (clinical research designation)
Peptide class	Synthetic tetrapeptide, Szeto-Schiller family
Primary research target	Inner mitochondrial membrane
Key research interaction	Cardiolipin binding and stabilization
Research themes	Oxidative stress, bioenergetics, and age-related mitochondrial decline
Research-use status	Laboratory research only, not FDA-approved

How Does SS-31 Stabilize Cardiolipin in the Inner Mitochondrial Membrane?

In pre-clinical research models, SS-31 selectively concentrates at the inner mitochondrial membrane and binds cardiolipin through a combination of electrostatic and hydrophobic interactions. This binding is reported to stabilize cristae architecture and support the organization of respiratory supercomplexes in the inner membrane, positioning SS-31 as a cardiolipin stabilizing peptide and a key research tool in mitochondrial membrane peptide investigation.

Cardiolipin and Its Role in Mitochondrial Architecture

Cardiolipin is the signature phospholipid of the inner mitochondrial membrane and plays a structural role that distinguishes mitochondria from other cellular compartments. It is concentrated in the cristae folds of the inner membrane and supports the assembly of respiratory supercomplexes that drive electron transport chain function. Cardiolipin’s unique double-headed structure also contributes to the high curvature of cristae membranes, and its integrity is closely tied to mitochondrial bioenergetic capacity. Under oxidative stress conditions, cardiolipin can undergo peroxidation, which disrupts cristae architecture and impairs mitochondrial function in research models.

How SS-31 Selectively Binds Cardiolipin

SS-31 binds cardiolipin through electrostatic interactions between the peptide’s cationic residues and cardiolipin’s anionic head groups, combined with hydrophobic interactions involving its aromatic residues and the lipid environment of the inner membrane. The result is a selective concentration of SS-31 at the inner mitochondrial membrane that does not depend on mitochondrial membrane potential, distinguishing it from many other mitochondria-targeted research tools. Pre-clinical research has reported that this binding stabilizes cristae architecture without disrupting normal mitochondrial polarization, which is part of why SS-31 is positioned as a structurally protective research compound rather than a pathway-disrupting one.

Research Observations on Cardiolipin Stabilization Outcomes

The following points summarize research outcomes most often reported in SS-31 cardiolipin pre-clinical literature.

Research Observations on Cardiolipin Stabilization

• Research interest in preserved cristae morphology under cellular stress conditions.
• Research interest in improved electron transport chain efficiency in stressed mitochondria.
• Research interest in reduced cardiolipin peroxidation in oxidative stress models.
• Research interest in maintained ATP synthesis capacity in aged or stressed cellular models.
• Research interest in reduced cytochrome c release in apoptosis research models.

What Does the Research Show About SS-31 and Age-Related Mitochondrial Decline?

Pre-clinical research on SS-31 spans mitochondrial dysfunction research, oxidative stress peptide research, and age-related cellular decline models, with endpoints including reactive oxygen species (ROS) production, mitochondrial membrane potential, ATP synthesis capacity, and tissue-level bioenergetic markers. The literature is descriptive of model behavior rather than predictive of human therapeutic outcomes, and SS-31 remains a research compound rather than an approved clinical agent.

SS-31 in Oxidative Stress Research Models

In oxidative stress research, SS-31 has been examined for its presence in studies of ROS production, mitochondrial membrane potential preservation, and oxidative damage attenuation in cellular and animal models. Research interest centers on how the cardiolipin-binding mechanism translates into observable effects on mitochondrial function under stress. Endpoints in this literature have included lipid peroxidation markers, ROS quantification, and mitochondrial morphology assessment, with research findings consistently grounded in non-clinical model systems.

SS-31 in Bioenergetic and Aging Research

Bioenergetic research on SS-31 has included studies of skeletal muscle mitochondrial function, cardiac mitochondrial research, and renal mitochondrial models, alongside broader age-related mitochondrial decline investigations. The research themes here connect to the molecule’s structural mechanism: by stabilizing cristae architecture and supporting electron transport chain organization, SS-31 is hypothesized to influence the bioenergetic capacity of stressed or aged mitochondria. These findings describe model behavior in cellular and animal systems.

SS-31 Mechanism of Action Summary

The SS-31 mechanism of action centers on selective concentration at the inner mitochondrial membrane and cardiolipin binding, which together support cristae stabilization, electron transport chain organization, and protection against cardiolipin peroxidation in pre-clinical research models. This mechanism distinguishes SS-31 from membrane-potential-dependent mitochondrial targeting strategies and accounts for its research positioning across oxidative stress and bioenergetic studies.

How Does SS-31 Compare to Other Mitochondria-Targeted Peptides Like MOTS-c?

SS-31 and MOTS-c are both mitochondria-targeted research peptides, but they differ substantially in origin, structure, and mechanism. SS-31 is a synthetic Szeto-Schiller tetrapeptide that targets the inner mitochondrial membrane and binds cardiolipin, while MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded by the 12S rRNA mitochondrial gene that signals through metabolic pathways involving AMPK activation. The two compounds are studied as complementary research tools rather than as interchangeable mitochondrial peptides.

SS-31 vs MOTS-c Research Profile

The comparison below summarizes the structural and research differences between SS-31 and MOTS-c.

SS-31 vs MOTS-c

Attribute	SS-31 Peptide	MOTS-c Peptide
Origin	Synthetic Szeto-Schiller tetrapeptide	Mitochondrial-derived 16-amino-acid peptide
Encoded by	Synthetic design	12S rRNA mitochondrial gene
Primary research site	Inner mitochondrial membrane	Cytosol and nucleus, mitochondrial communication
Key research interaction	Cardiolipin binding and stabilization	AMPK pathway and metabolic signaling
Research themes	Oxidative stress, cristae stability, bioenergetics	Metabolic homeostasis and insulin sensitivity research
Research focus	Mitochondrial structure and function preservation	Mitochondrial-nuclear signaling and metabolism

Why SS-31 and MOTS-c Are Studied as Complementary Research Tools

SS-31 and MOTS-c address different aspects of mitochondrial biology, which is why they are positioned as complementary research tools rather than competitors. SS-31 acts at the structural level of the inner mitochondrial membrane, supporting cristae architecture and electron transport chain organization. MOTS-c operates as a signaling peptide that connects mitochondrial function to broader metabolic regulation through AMPK pathway interaction and mitochondrial-nuclear communication. Combined research using both compounds can address structural and signaling questions in parallel, which is part of why both appear in modern mitochondrial peptide research designs.

Where Can Researchers Source High-Purity SS-31 Peptide in the United States?

High-purity SS-31 peptide is available through specialized research peptide suppliers in the United States that publish independent third-party laboratory verification, provide per-batch certificates of analysis, and restrict sales to qualified research buyers. Sourcing standards in this category matter because mitochondrial research depends heavily on the analytical fidelity of input compounds.

What to Verify Before Sourcing Research-Grade SS-31 Peptide

The following points summarize what reference-grade SS-31 procurement should include.

Sourcing Verification Checklist

• Third-party COA from independent U.S. laboratories with batch-specific results.
• Documented purity percentages confirmed by HPLC and mass spectrometry.
• Cold-chain shipping protocols and lyophilized-state delivery.
• Transparent batch numbers, lot tracking, and synthesis documentation.
• Clear research-use-only labeling and compliance with applicable research-product regulations.

Why Purity Matters in Mitochondrial Peptide Research

Mitochondrial peptide research relies on high-fidelity inputs because impurities can confound oxidative stress and bioenergetic measurements. ROS quantification, membrane potential assays, and cardiolipin peroxidation endpoints are sensitive to contaminants in the source material, and even small deviations in analytical purity can introduce noise that masks the signal a study is designed to capture. Reference-grade material with documented HPLC and mass spectrometry verification, paired with batch-level COAs, is the practical standard for mitochondrial peptide work.

People Also Ask

Is SS-31 the Same as Elamipretide?

SS-31 and elamipretide refer to the same molecule, with SS-31 used in preclinical and basic research literature and elamipretide used as the clinical research designation. The dual nomenclature reflects the molecule’s transition from early Szeto-Schiller laboratory research into broader clinical investigation, and both designations appear across the peer-reviewed mitochondrial research literature. Researchers selecting publications for review should be aware of both names to capture the full scope of the molecule’s research base.

How Does SS-31 Peptide Work?

SS-31 selectively concentrates at the inner mitochondrial membrane and binds cardiolipin through electrostatic and hydrophobic interactions, supporting cristae architecture and electron transport chain organization in pre-clinical research models. The mechanism does not depend on mitochondrial membrane potential, which distinguishes it from many other mitochondria-targeted research tools. This combination of selectivity, mechanism, and membrane-potential independence accounts for its prominence in mitochondrial peptide research.

Why Is SS-31 Called a Mitochondrial-Targeted Peptide?

SS-31 is called a mitochondrial-targeted peptide because its structural design (the alternating aromatic-cationic amino acid motif) causes it to selectively concentrate at the inner mitochondrial membrane independent of membrane potential. This selectivity is a defining feature of the Szeto-Schiller peptide family and underpins SS-31’s role as a research tool for studying mitochondrial structure and function in non-clinical models.

What Role Does Cardiolipin Play in SS-31 Research?

Cardiolipin functions as the primary binding target for SS-31 in pre-clinical research models, and its central role in inner mitochondrial membrane architecture is what makes SS-31’s cardiolipin-stabilizing activity research-relevant. Cardiolipin organizes respiratory supercomplexes, supports cristae curvature, and is vulnerable to oxidative damage under stress conditions. SS-31’s interaction with cardiolipin is the mechanistic foundation for much of the molecule’s research positioning.

How Does SS-31 Relate to Oxidative Stress Research?

SS-31’s cardiolipin-stabilizing mechanism connects directly to oxidative stress peptide research, because cardiolipin peroxidation is one of the primary mechanisms by which oxidative damage disrupts mitochondrial function. By binding cardiolipin and supporting cristae integrity, SS-31 is investigated in pre-clinical models of ROS reduction, oxidative damage attenuation, and mitochondrial dysfunction research, where structural protection of the inner membrane is part of the research hypothesis.

Expert Viewpoint: The Research Director’s Perspective on SS-31 Peptide

SS-31 occupies a distinct position in mitochondrial peptide research because of its selective inner-membrane targeting and direct interaction with cardiolipin. Unlike membrane-potential-dependent strategies, SS-31’s structural design enables it to concentrate at the inner mitochondrial membrane regardless of polarization status, which makes it a useful research tool for studying mitochondria under stress conditions where membrane potential is compromised.

The molecule’s dual nomenclature (SS-31 in preclinical research, elamipretide in clinical research) reflects its prominence across both research domains. This is unusual for peptides in this category and signals the depth of the published literature, with research themes spanning oxidative stress, age-related mitochondrial decline, and bioenergetic studies in skeletal muscle, cardiac, and renal tissue models.

The integrity of mitochondrial peptide research depends entirely on verified purity and traceability of input material. Mitochondrial endpoints are sensitive to impurities and analytical variability, which makes third-party U.S. laboratory testing non-negotiable for reference-grade work. HPLC purity at or above 99%, mass spectrometry identity confirmation, and batch-level COAs form the practical floor for legitimate research material in this category.

The role of mitochondria-targeted peptides in cellular research continues to expand, with growing attention to the structural, signaling, and metabolic dimensions of mitochondrial biology.

---

Frequently Asked Questions About SS-31 Peptide